This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1 NAPNAP contact hour, of which 0.25 is pharmacology.

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP.  If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: 


Copyright 2018 © by National Association of Pediatric Nurse Practitioners (NAPNAP)

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

• List the major and minor criteria for PANDAS diagnosis.
• Review how to start treatment for PANDAS in the primary setting.
• Identify laboratory tests that can assist in making the diagnosis and treatment plan.

Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
Course expires: 

Jennifer Gagnon, MSN, CPNP, FNP-C, Nurse Practitioner, Latimer Neurology Center, Washington


None to Report

Jennifer Gagnon reported the below pharmaceuticals and/or medical devices that may be discussed for off-label use:

 bio-therapeutic agents (Rituxamib), antibiotics (macrolides, sulfonamides, penicillin and cephalosporins), IVIG

Available Credit

  • 1.00 Contact hours


Please login or register to take this course.